The value of CHA2DS2-VASc-HS score for prediction of adverse in-hospital outcomes in patients with non-ST segment elevation myocardial infarction | ||||
| Benha Journal of Applied Sciences | ||||
| Article 29, Volume 6, Issue 4, August 2021, Page 191-196 PDF (498.83 K) | ||||
| Document Type: Original Research Papers | ||||
| DOI: 10.21608/bjas.2021.189923 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| M.K. Mahmoud; H.M. Kabil; H.H. Ebed; A.M. Sabry | ||||
| Cardiology, Dept., Faculty of Medicine, Benha Univ., Benha, Egypt | ||||
| Abstract | ||||
| For a treatment choice the early identification of non-ST myocardial infarction segment patients (NSTEMI) with poor in-hospital results is essential. The CHA2DS2-VASc-HS and CHA2DS2-VASc score was recently reported as a predictor of severity and poor outcomes in individuals with stable coronary artery disease (CAD) and acute coronary syndrome. Our research aimed at evaluating the precision of the CHA2DS2-VASc-HS score, which predicts poor outcomes in hospitals in NSTEMI patients. 120 NSTEMI patients have been enrolled. The score for CHA2DS2-VASc-HS has been computed. The participants of the research were split into two groups. Group I and Group II score <4 were placed in Patients with CHA2DS2-VASc-HS score>4. Patients with CHA2DS2-VASc-HS >4 were found to have higher unfavourable outcomes in the hospital than the CHA2DS2-VASc-HS score <4. | ||||
| Keywords | ||||
| Ischemic heart disease; CHA2DS2-VASc-HS score; adverse in-hospital outcomes; non-ST segment elevation myocardial infarction | ||||
|
Statistics Article View: 109 PDF Download: 291 |
||||
